FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945760995> ?p ?o ?g. }

• W2945760995 endingPage "28" @default.
• W2945760995 startingPage "15" @default.
• W2945760995 abstract "Melanoma remains one of the most challenging malignant tumor related deaths worldwide and alternative approaches to efficiently treat melanoma are eagerly needed. Anti-PD1 antibody (aPD1) immunotherapy is the most significant and impactful therapy for melanoma by immune checkpoint inhibition and T cell stimulation to mediate tumor killing. But the clinical remission rate of aPD1 immunotherapy is limited in melanoma. Here we show a potent combination of aPD1 and photothermal therapy (PTT) by effective delivery of a multifunctional phase-transformation nanocarrier to melanoma tumor. We successfully synthesized multifunctional nanoparticles (NPs) encapsulated with aPD1, iron oxide and perfluoropentane (PFP) in lactic-co-glycolic acid (PLGA) shell modified with poly ethylene glycol (PEG) and Gly-Arg-Gly-Asp-Ser (GRGDS) peptides ([email protected]). In vitro, [email protected] NPs were characterized for particle size and drug-loading efficiency. The NPs were also tested for photothermal property, optical droplet vaporization (ODV) capacity and the ability of aPD1 release profile. In vivo, [email protected] NPs were systemically administered to melanoma-bearing mice demonstrated no toxicity and accumulation at tumor site. When mediated with PTT, this synergistic treatment achieved enhanced antitumor efficacy, due to combination of the effective aPD1 release and increased CD8+ T cell infiltration in tumor site. In conclusion, [email protected] NPs combined with PTT could potentiate the efficacy of aPD1 not only by tumor-targeted delivery of aPD1 but also by activating the immune system in the tumor microenvironment, which is a highly effective approach to treat melanoma." @default.
• W2945760995 created "2019-05-29" @default.
• W2945760995 creator A5001154049 @default.
• W2945760995 creator A5006996556 @default.
• W2945760995 creator A5008659449 @default.
• W2945760995 creator A5010437886 @default.
• W2945760995 creator A5029117570 @default.
• W2945760995 creator A5051062987 @default.
• W2945760995 creator A5055377723 @default.
• W2945760995 creator A5060185042 @default.
• W2945760995 creator A5062165449 @default.
• W2945760995 creator A5066599847 @default.
• W2945760995 creator A5068595187 @default.
• W2945760995 creator A5082981730 @default.
• W2945760995 date "2019-07-01" @default.
• W2945760995 modified "2023-10-18" @default.
• W2945760995 title "Photothermal therapy mediated by phase-transformation nanoparticles facilitates delivery of anti-PD1 antibody and synergizes with antitumor immunotherapy for melanoma" @default.
• W2945760995 cites W1039337982 @default.
• W2945760995 cites W1527151869 @default.
• W2945760995 cites W1968583232 @default.
• W2945760995 cites W1978669608 @default.
• W2945760995 cites W1997446339 @default.
• W2945760995 cites W2030694165 @default.
• W2945760995 cites W2039123767 @default.
• W2945760995 cites W2039171477 @default.
• W2945760995 cites W2042669918 @default.
• W2945760995 cites W2049553585 @default.
• W2945760995 cites W2054198142 @default.
• W2945760995 cites W2060070314 @default.
• W2945760995 cites W2066671159 @default.
• W2945760995 cites W2088659772 @default.
• W2945760995 cites W2102866212 @default.
• W2945760995 cites W2108157005 @default.
• W2945760995 cites W2112417311 @default.
• W2945760995 cites W2118982164 @default.
• W2945760995 cites W2122375865 @default.
• W2945760995 cites W2124626073 @default.
• W2945760995 cites W2136337147 @default.
• W2945760995 cites W2140571082 @default.
• W2945760995 cites W2143772132 @default.
• W2945760995 cites W2155203762 @default.
• W2945760995 cites W2156260681 @default.
• W2945760995 cites W2160721775 @default.
• W2945760995 cites W2160834915 @default.
• W2945760995 cites W2162910628 @default.
• W2945760995 cites W2164001237 @default.
• W2945760995 cites W2179431183 @default.
• W2945760995 cites W2187117619 @default.
• W2945760995 cites W2253777559 @default.
• W2945760995 cites W2299181842 @default.
• W2945760995 cites W2308809093 @default.
• W2945760995 cites W2320589001 @default.
• W2945760995 cites W2506616866 @default.
• W2945760995 cites W2509453883 @default.
• W2945760995 cites W2513541135 @default.
• W2945760995 cites W2533513686 @default.
• W2945760995 cites W2558284519 @default.
• W2945760995 cites W2581440232 @default.
• W2945760995 cites W2591838344 @default.
• W2945760995 cites W2609289346 @default.
• W2945760995 cites W2750781282 @default.
• W2945760995 cites W2766010926 @default.
• W2945760995 cites W2787857200 @default.
• W2945760995 cites W2791406819 @default.
• W2945760995 cites W2791440760 @default.
• W2945760995 cites W2797309423 @default.
• W2945760995 cites W2801825429 @default.
• W2945760995 cites W2885845278 @default.
• W2945760995 cites W2890361448 @default.
• W2945760995 cites W2891582847 @default.
• W2945760995 cites W4232041547 @default.
• W2945760995 doi "https://doi.org/10.1016/j.jconrel.2019.05.036" @default.
• W2945760995 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31132380" @default.
• W2945760995 hasPublicationYear "2019" @default.
• W2945760995 type Work @default.
• W2945760995 sameAs 2945760995 @default.
• W2945760995 citedByCount "80" @default.
• W2945760995 countsByYear W29457609952020 @default.
• W2945760995 countsByYear W29457609952021 @default.
• W2945760995 countsByYear W29457609952022 @default.
• W2945760995 countsByYear W29457609952023 @default.
• W2945760995 crossrefType "journal-article" @default.
• W2945760995 hasAuthorship W2945760995A5001154049 @default.
• W2945760995 hasAuthorship W2945760995A5006996556 @default.
• W2945760995 hasAuthorship W2945760995A5008659449 @default.
• W2945760995 hasAuthorship W2945760995A5010437886 @default.
• W2945760995 hasAuthorship W2945760995A5029117570 @default.
• W2945760995 hasAuthorship W2945760995A5051062987 @default.
• W2945760995 hasAuthorship W2945760995A5055377723 @default.
• W2945760995 hasAuthorship W2945760995A5060185042 @default.
• W2945760995 hasAuthorship W2945760995A5062165449 @default.
• W2945760995 hasAuthorship W2945760995A5066599847 @default.
• W2945760995 hasAuthorship W2945760995A5068595187 @default.
• W2945760995 hasAuthorship W2945760995A5082981730 @default.
• W2945760995 hasConcept C150903083 @default.
• W2945760995 hasConcept C171250308 @default.
• W2945760995 hasConcept C178790620 @default.
• W2945760995 hasConcept C18150654 @default.

• next